一、审议通过《关于使用自有资金支付募投项目人员费用并以募集资金等额置换 的议案》 监事会认为：公司根据实际需要使用自有资金先行支付募投项目人员费用，后续 定期以募集资金专项账户划转等额款项至公司相关自有资金账户，能够提高资金使用 效率，不影响公司募投项目和日常经营的正常开展，不存在变相改变募集资金用途和 损害公司及股东利益的情形，符合公司发展的需要。综上，监事会同意使用自有资金 支付募投项目人员费用并以募集资金等额置换事项。 表决结果：同意票3票，反对票0票，弃权票0票。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《广州 慧智微电子股份有限公司关于使用自有资金支付募投项目人员费用并以募集资金等额 置换的公告》（公告编号：2025-027）。 二、审议通过《关于注销2021年股票期权激励计划部分股票期权的议案》 证券代码：688512 证券简称：慧智微 公告编号：2025-026 广州慧智微电子股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广州慧智微电子股份有限公司（以下简 ...

Core Viewpoint - The announcement details the first vesting period of the 2024 restricted stock incentive plan for Changzhou Juhe New Materials Co., Ltd, confirming that 1.2715 million shares will vest for 142 eligible participants based on performance criteria [1][10][21] Group 1: Incentive Plan Overview - The total number of restricted shares to be granted under the incentive plan is 3.8 million, accounting for approximately 1.57% of the company's total share capital [1] - The first grant consists of 3.586 million shares, representing about 1.48% of the total share capital at the time of the announcement [1] - The vesting schedule includes three periods: 40% after 12 months, 30% after 24 months, and 30% after 36 months [1][2] Group 2: Performance Assessment Criteria - The performance assessment for the first vesting period requires a revenue growth rate of at least 20% based on 2023 figures [2][3] - The second and third vesting periods have higher targets of 44% and 72.8% revenue growth, respectively [3] - The assessment will also consider the growth rate of photovoltaic conductive silver paste shipments, with similar percentage targets [2][3] Group 3: Vesting Conditions and Procedures - The board confirmed that the first vesting period conditions have been met, allowing for the vesting of 1.2715 million shares [10][21] - The vesting is contingent upon the company not having any adverse audit opinions or regulatory issues in the past year [11][12] - The company will process the vesting and related share registration according to regulatory guidelines [20] Group 4: Stock Grant Details - The adjusted grant price for the restricted shares is set at 18.33 yuan per share, down from 18.74 yuan due to a rights issue [8][9] - A total of 142 individuals are eligible for the first vesting, with specific performance ratings determining individual share allocation [18][19] - The company has invalidated 38.05 thousand shares due to the departure of certain participants [9][15]

证券代码：688136 证券简称：科兴制药 公告编号：2025-048 科兴生物制药股份有限公司 关于 2024 年限制性股票激励计划第一个归属期归属结果 暨股份上市的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为 本次股票上市流通总数为1,615,000股。 ? 本次股票上市流通日期为2025 年 7 月 16 日。 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责 任公司上海分公司有关业务规则的规定，科兴生物制药股份有限公司(以下简称"公 司")于近日收到中国证券登记结算有限责任公司上海分公司出具的《证券变更登记 证明》，公司已完成 2024 年限制性股票激励计划（以下简称"本激励计划"）第一个 归属期归属（以下简称"本次归属"）的股份登记工作。现将有关情况公告如下： 一、本次限制性股票归属的决策程序及相关信息披露 于公司<2024 年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2024 年限制性股票 ...

Core Viewpoint - The company has announced the achievement of vesting conditions for the third vesting period of the initial grant and the second vesting period of the reserved grant under the 2022 Restricted Stock Incentive Plan, allowing a total of 126 individuals to receive shares [1][2][21]. Summary by Sections Incentive Plan Overview - The 2022 Restricted Stock Incentive Plan was approved on July 4, 2022, with a total grant of 2.6 million shares, representing 1.41% of the company's total share capital at the time [2][3]. - The initial grant consisted of 2.25 million shares, with a grant price of 7.64 yuan per share [3][4]. Vesting Conditions and Achievements - For the initial grant's third vesting period, 82 individuals are eligible to receive 1.016668 million shares, while 47 individuals in the reserved grant's second vesting period are eligible for 219,912 shares [2][19]. - The adjusted vesting price is set at 4.28 yuan per share [1][19]. Performance Assessment - The performance assessment for the vesting conditions includes company-level and individual-level evaluations, with specific revenue and net profit growth targets set for the years 2022 to 2024 [5][6][18]. - The company achieved a net profit of approximately 162 million yuan for 2024, reflecting an 83.58% increase compared to 2021, thus meeting the performance criteria for the vesting conditions [18]. Adjustments and Cancellations - Adjustments to the grant price and number of shares have been made over time, with the initial grant price adjusted from 7.64 yuan to 4.28 yuan [15][24]. - A total of 93,140 shares were canceled due to individuals no longer qualifying as incentive recipients [15][23]. Compliance and Approval - The board and supervisory committee have confirmed that the vesting conditions have been met and that the incentive plan complies with relevant laws and regulations [21][23][25]. - The company will continue to fulfill its disclosure obligations as required by law [24][26].

Core Viewpoint - The company announced the cancellation of 194,000 stock options from the 2021 stock option incentive plan due to the departure of one incentive object and the expiration of the exercise period for another group of incentive objects [1][10]. Group 1: Stock Option Incentive Plan - The total number of stock options reserved in the 2021 stock option incentive plan is 5.5 million, with an exercise price set at 4 yuan per registered capital [1]. - The company has made adjustments to the stock option plan, including a reduction in the total number of options to no more than 22 million and a new exercise price of 1 yuan per share [3]. - The board approved the exercise of stock options for 57 incentive objects during the first exercise period, while 320,000 options were canceled due to the departure of 5 incentive objects [4][10]. Group 2: Cancellation of Stock Options - The cancellation of stock options includes 48,000 options from one departing incentive object and 146,000 options that were not exercised by another group after the expiration of their exercise period [10]. - The cancellation aligns with the regulations of the 2021 stock option incentive plan and will not materially affect the company's financial status or operational results [10][11]. - The supervisory board confirmed that the cancellation complies with the relevant provisions of the stock option incentive plan and does not harm the interests of the company or its shareholders [10].

证券代码：002581 证券简称：未名医药 公告编号：2025-047 山东未名生物医药股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，不存在虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 山东未名生物医药股份有限公司（以下简称"公司"）控股子公司天津未名 生物医药有限公司（以下简称"天津未名"）于 2025 年 4 月 22 日被采取暂停生 产、销售风险控制措施。2025 年 7 月 4 日，因试验进度未及预期，天津未名预 计在三个月内无法恢复正常生产经营活动，上述情形触及《深圳证券交易所股票 上市规则》（2025 年修订）中公司被实施其他风险警示的有关规定，公司股票交 易被实施其他风险警示，自 2025 年 7 月 8 日开市起，证券简称由"未名医药" 变更为"ST 未名"，股票交易日涨跌幅限制 5%。 一、股票交易异常波动的情况 山东未名生物医药股份有限公司（以下简称"公司"）股票交易价格于 2025 年 7 月 8 日、2025 年 7 月 9 日、2025 年 7 月 10 日连续三个交易日收盘价格跌幅 累计偏离-15.82%，根据深圳证券交易所的有关规定，属于股票交易异 ...

最近两年，全球经J都不太平。 又是地缘冲突、又是经J数据低迷。 全球经济似乎已经到了危机的边缘。 但是，巴菲特在今年致股东的信中就告诫过我们： 为什么呢？ 因为每一次危机之后，都是一次财富转移。 而每一次财富转移，都是 我们每个普通人实现财富进阶的机会。 过去40年，我们经历了两轮的大规模财富转移。 第一次大规模财富转移，是在上世纪90年代。 90年代初期，苏东巨变、苏联解体，我们的经济也因为价格闯关受到了冲击，通胀率一度高达 20%以上。 但就在这一场经J危机之后，我们开启了第一轮的财富转移。 不要浪费每一次的危机 这一次财富转移的源头是 工业化+城市化的浪潮 。 工业化+城市化，带动的是财富、人口以及土地资源逐渐从农村流向城市。 所以在这个阶段，你能看到8亿农民进城、你能看到大量农田和G有土地被转化成了工业用地和城 市住宅用地，导致了土地产权的大调整。 而第一轮的财富转移，主要的方式是 以地生财 。 土地通过30年的房贷，用撬动杠杆的方式撬动了财富循坏。 钱都跑到土地和房子上面流转了，自然会把这一部分资产价格拉上去。 所以，作为普通人，如果你能在这个时间段在农村拥有一块地，或者是在城市里拥有一套房，那 你 ...

7月10日，嬴集团回购600.00万股股票，每股回购均价0.06港元，共耗资约33.10万港元，本年累计回购 1.82亿股，占总股本7.66%。 截至当日港股收盘，嬴集团下跌3.51%，报0.055港元/股。 本文源自：金融界 作者：港股君 回购日期回购均价回购股数回购金额本年累计回购股数2025-07-100.055600.00万33.10万1.82亿2025-07- 090.057800.00万45.80万1.76亿2025-07-070.058220.00万12.78万1.68亿2025-07-040.061670.00万41.14万 1.65亿2025-07-030.063550.00万34.65万1.59亿2025-07-020.062400.00万24.80万1.53亿2025-06- 270.0671070.00万71.69万1.49亿2025-06-250.064500.00万32.00万1.39亿2025-05-260.0661500.00万98.47万 1.34亿2025-05-230.064550.00万35.35万1.19亿2025-05-220.06381.00万5.14万1.13亿 ...

Group 1 - The core viewpoint of the article highlights that Mobi Development has been actively repurchasing its shares, indicating management's confidence in the company's financial health and future prospects [1][3] - As of July 10, 2025, Mobi Development repurchased 83,000 shares at an average price of HKD 0.12 per share, totaling approximately HKD 9,918, with a cumulative repurchase of 3.821 million shares this year, representing 0.47% of the total share capital [1] - The recent share repurchase activity is seen as a strategy to stabilize the stock price and enhance investor confidence, while also potentially improving financial metrics such as earnings per share by reducing the number of shares in circulation [1] Group 2 - Mobi Development operates in the telecommunications sector, focusing on the research, development, and production of communication infrastructure equipment [2] - The company provides products and solutions for communication network construction, including base station antennas and RF devices, and maintains business relationships with various telecom operators [2] - The company's performance and growth prospects are influenced by the overall trends in the telecommunications industry, market competition, and its own technological innovation capabilities [2]

归创通桥近期回购情况 本文源自：金融界 7月10日，归创通桥回购5.00万股股票，每股回购均价19.68港元，共耗资约98.40万港元，本年累计回购 369.45万股，占总股本1.16%。 回购日期回购均价回购股数回购金额本年累计回购股数2025-07-1019.6805.00万98.40万369.45万2025-07- 0919.8505.00万99.25万364.45万2025-07-0819.8445.00万99.22万359.45万2025-07-0720.5115.00万102.56万 354.45万2025-07-0420.7875.00万103.94万349.45万2025-07-0320.8285.00万104.14万344.45万2025-06- 3020.7743.50万72.71万339.45万2025-06-2720.1102.40万48.26万335.95万2025-06-2619.9233000.005.98万 333.55万2025-06-2519.3792.45万47.48万333.25万2025-06-2419.2235.00万96.11万330.80万2025-06- 23 ...